Clinical Trials Browser

Not yet recruiting × OTHER × Adalimumab × Clear all

NCT06833112 2025-02-18

Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis

Phase 4 Not yet recruiting

Spondylitis, Ankylosing